Many may have seen it coming, but the scale and depth of a renewed anti-corruption campaign in China are still shocking and the pharma/health sector is firmly in authorities' sights.
China’s New Pharma Corruption Push Set For At Least A Year
Industry Group Issues New Guidance
As Beijing gets tougher in an all-out campaign to root out corruption and non-compliance in the pharma sector, more physician conferences are jeopardized and an increasing number of hospital presidents are placed under investigation. Meanwhile, one industry association issues new guidance for members.
